Document Detail


Interchangeability of Activated Clotting Time Values Across Different Point-of-Care Systems.
MedLine Citation:
PMID:  22341924     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Significant variability in activated clotting time (ACT) measurement exists based on the type of point-of-care system used. We sought to determine the degree of agreement in ACT measurements by the Hemochron Response and the Hemochron Signature Elite Whole Blood coagulation systems and whether these 2 systems can be used interchangeably. We prospectively compared 126-paired samples in 77 patients undergoing percutaneous coronary intervention. ACT was measured for each sample using the Hemochron Response system with glass test tubes and the Hemochron Signature Elite system with low-range ACT cuvettes simultaneously. We used correlation and Bland-Altman analyses. Mean age of the study cohort was 67 ± 11 years, 49% were women, and 65% of measurements were made after systemic anticoagulation. There was a significant correlation between the Hemochron Response and Hemochron Signature Elite systems (r = 0.84, p <0.01). However, the mean bias for the ACT measurement was 9 seconds (95% confidence interval -69 to 86). In the therapeutic range of ACT measurements, the mean bias was 15 seconds (95% confidence interval -60 to 91). Thirty-three percent of total samples had >10% disagreement and 8% of samples had >20% disagreement in the ACTs measured with the Hemochron Response compared to the Hemochron Signature Elite. In conclusion, the Hemochron Response and Hemochron Signature Elite ACT values cannot be used interchangeably. Institutions using these 2 devices should be cognizant of this difference for ensuring patient safety.
Authors:
Thenappan Thenappan; Rajiv Swamy; Atman Shah; Sandeep Nathan; Jearlyn Nichols; Linda Bond; Neeraj Jolly
Related Documents :
22846934 - The national trauma triage protocol: can this tool predict which patients with trauma w...
8605054 - Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxi...
22295934 - Pilot 24 month study to compare mycophenolate mofetil and tacrolimus in the treatment o...
16807254 - Timing of vancomycin prophylaxis for cardiac surgery patients and the risk of surgical ...
16359154 - Nitinol stents in the treatment of benign proximal tracheal stenosis or tracheomalacia.
14567804 - Gnrh agonist treatment before total laparoscopic hysterectomy for large uteri.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-2-14
Journal Detail:
Title:  The American journal of cardiology     Volume:  -     ISSN:  1879-1913     ISO Abbreviation:  -     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-2-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Inc. All rights reserved.
Affiliation:
Section of Cardiology, University of Chicago, Chicago, Illinois.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hemodynamic characteristics and predictors of pulmonary hypertension in patients with sickle cell di...
Next Document:  Safety and Efficacy of the XIENCE V Everolimus-Eluting Stent Compared to First-Generation Drug-Eluti...